Inventor
GREVE JEFFREY
US16 patents
⚠️ This page may combine multiple inventors who share the name “GREVE JEFFREY”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
DELINIA INC
9 patentsUS10294287B2May 21, 2019
Molecules that selectively activate regulatory T cells for the treatment of autoimmune diseases
DELINIA INC22 citations93
US10035836B1Jul 31, 2018
Modified IL-2 variants that selectively activate regulatory T cells
DELINIA INC47 citations93
US10774126B2Sep 15, 2020
Molecules that selectively activate regulatory T cells for the treatment of autoimmune diseases
DELINIA INC4 citations83
US10875901B2Dec 29, 2020
Molecules that selectively activate regulatory T cells for the treatment of autoimmune diseases
DELINIA INC1 citations72
US10766938B2Sep 8, 2020
Nucleic acid encoding human IL-2 variant
DELINIA INC2 citations72
US10472405B2Nov 12, 2019
Multivalent regulatory T cell modulators
DELINIA INC3 citations70
US11535657B2Dec 27, 2022
Molecules that selectively activate regulatory T cells for the treatment of autoimmune diseases
DELINIA INC0 citations61
US11077172B2Aug 3, 2021
IL-2 variants for the treatment of psoriasis
DELINIA INC1 citations61
US11059877B2Jul 13, 2021
Multivalent regulatory T cell modulators
DELINIA INC1 citations59
ATYR PHARMA INC
4 patentsUS8835387B2Sep 16, 2014
Histidyl-tRNA synthetases for treating autoimmune and inflammatory diseases
ATYR PHARMA INC18 citations90
US9273302B2Mar 1, 2016
Histidyl-tRNA synthetases for treating autoimmune and inflammatory diseases
ATYR PHARMA INC10 citations82
US9822353B2Nov 21, 2017
PEGylated aspartyl-tRNA synthetase polypeptides
ATYR PHARMA INC2 citations71
US9816084B2Nov 14, 2017
Aspartyl-tRNA synthetases
ATYR PHARMA INC0 citations51